Division of Clinical Behavioral Neuroscience, Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA.
Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
Mol Genet Metab. 2022 Feb;135(2):122-132. doi: 10.1016/j.ymgme.2022.01.001. Epub 2022 Jan 7.
To assess our hypothesis that brain macrostructure is different in individuals with mucopolysaccharidosis type I (MPS I) and healthy controls (HC), we conducted a comprehensive multicenter study using a uniform quantitative magnetic resonance imaging (qMRI) protocol, with analyses that account for the effects of disease phenotype, age, and cognition.
Brain MRIs in 23 individuals with attenuated (MPS IA) and 38 with severe MPS I (MPS IH), aged 4-25 years, enrolled under the study protocol NCT01870375, were compared to 98 healthy controls.
Cortical and subcortical gray matter, white matter, corpus callosum, ventricular and choroid plexus volumes in MPS I significantly differed from HC. Thicker cortex, lower white matter and corpus callosum volumes were already present at the youngest MPS I participants aged 4-5 years. Age-related differences were observed in both MPS I groups, but most markedly in MPS IH, particularly in cortical gray matter metrics. IQ scores were inversely associated with ventricular volume in both MPS I groups and were positively associated with cortical thickness only in MPS IA.
Quantitatively-derived MRI measures distinguished MPS I participants from HC as well as severe from attenuated forms. Age-related neurodevelopmental trajectories in both MPS I forms differed from HC. The extent to which brain structure is altered by disease, potentially spared by treatment, and how it relates to neurocognitive dysfunction needs further exploration.
为了验证我们的假设,即黏多糖贮积症 I 型(MPS I)患者的大脑宏观结构与健康对照者(HC)不同,我们采用统一的定量磁共振成像(qMRI)方案进行了一项综合性多中心研究,分析中考虑了疾病表型、年龄和认知的影响。
根据研究方案 NCT01870375,对 23 名轻中度 MPS IA 患者和 38 名重度 MPS I(MPS IH)患者(年龄 4-25 岁)的脑部 MRI 进行了分析,并与 98 名健康对照者进行了比较。
MPS I 患者的皮质和皮质下灰质、白质、胼胝体、脑室和脉络丛体积与 HC 存在显著差异。最年轻的 MPS I 患者(4-5 岁)已经存在皮质增厚、白质和胼胝体体积降低的现象。在两个 MPS I 组中均观察到与年龄相关的差异,但在 MPS IH 中更为明显,尤其是在皮质灰质指标中。智商评分与两个 MPS I 组的脑室体积呈负相关,仅在 MPS IA 中与皮质厚度呈正相关。
定量 MRI 测量结果可区分 MPS I 患者与 HC 以及重度与轻度患者。两种 MPS I 形式的与年龄相关的神经发育轨迹与 HC 不同。疾病对大脑结构的改变程度、治疗可能对其的保护程度以及其与神经认知功能障碍的关系,还需要进一步探索。